Please login to the form below

Not currently logged in
Email:
Password:

gene sequencing

This page shows the latest gene sequencing news and features for those working in and with pharma, biotech and healthcare.

Grail’s multi-cancer blood test gets FDA breakthrough status

Grail’s multi-cancer blood test gets FDA breakthrough status

Grail is a spin-out of genome sequencing giant Illumina, and is leveraging the whole genome sequencing (WGS) power of its parent company with the goal of revolutionising cancer diagnostics. ... Unlike existing tests, Grail's technology is based on vast

Latest news

  • UK ‘unicorn’ Oxford Nanopore bags $65m backing from Amgen UK ‘unicorn’ Oxford Nanopore bags $65m backing from Amgen

    Big biopharma investment good news for gene sequencing company. Amgen has taken a £50m ($66m) minority stake in Oxford Nanopore Technologies (ONT), a UK company making waves in the genetic sequencing ... Illumina and smaller players like Pacific

  • UK trumpets life sciences post-Brexit ‘sector deal’ UK trumpets life sciences post-Brexit ‘sector deal’

    GSK said the new cash will expand its commitment to the UK Biobank gene sequencing effort – allowing all 500, 000 genomes to be sequenced – and will strengthen its ‘open targets’ collaboration

  • Roche buys gene sequencing firm Roche buys gene sequencing firm

    Roche has cemented a long-running partnership with gene sequencing specialist Kapa Biosystems with an agreement to take over the company. ... Since then, Roche has been steadily expanding its gene sequencing and molecular diagnostics capabilities through

  • AZ to screen 80,000 patients for genetic disease traits AZ to screen 80,000 patients for genetic disease traits

    Researchers will then apply further technologies to carry out full gene sequencing of areas of interest in order to identify new genes associated with the diseases. .

  • DNA expert: use genes to assess disease risk DNA expert: use genes to assess disease risk

    The debate on gene sequencing comes at a crucial time, with Dr Hood predicting that the price to sequence a genome, and therefore assess a person's potential to develop diseases ... Astellas also discovered that healthcare professionals were cautious

More from news
Approximately 7 fully matching, plus 11 partially matching documents found.

Latest Intelligence

  • AstraZeneca’s oncology renaissance AstraZeneca’s oncology renaissance

    AstraZeneca is collaborating with numerous firms in this field, including Foundation Medicine, which specialises in next-generation gene sequencing technology. ... People who have BRCA gene mutations have an increased risk of certain cancers, including

  • Under pressure Under pressure

    It is based on technologies, such as bioinformatics, gene sequencing, biomarkers and synthetic biology that make systems biology and systems medicine possible.

  • Harnessing complexity Harnessing complexity

    DNA changes can only be detected with sophisticated machinery that relies on advanced techniques such as real time polymerase chain reactions (PCR) and, increasingly, full gene sequencing. ... Next Generation Sequencing has been gradually increasing in

  • Pharma deals during February 2014 Pharma deals during February 2014

    In the meantime, Roche's pRED group will make use of Discuva's development technology, which uses gene sequencing and bioinformatics to identify targets for multi-drug resistant Gram-negative bacteria,

  • Pharma deals during September 2013 Pharma deals during September 2013

    Strengthening another of its business units, Roche's diagnostic arm announced a licensing deal with Pacific Bioscience for human in vitro diagnostic (IVD) gene sequencing technology, paying $35m upfront and additional ... Antisense technology is

More from intelligence
Approximately 0 fully matching, plus 5 partially matching documents found.

Latest from PMHub

  • Rare Disease Day in a COVID-19 environment

    New gene sequencing methods have recently opened doors to earlier diagnosis, though, with the multitude of possible gene mutations, clinical interpretation in terms of diagnosis or severity is not always possible.

  • 03 Health Services

    Many areas of healthcare have already been busy harnessing the potential of digital in innovative technical ways: gene sequencing, diagnostic imaging, telemedicine, electronic medical records, and so on.

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
certain health

Transforming the way health brands and companies communicate, we deliver creative science led, insight-driven solutions that give award winning results...

Latest intelligence

InSite Events™ National Pharma Meeting: A Customer Story
How our client leveraged Impetus Digital’s white-glove service, 360° coverage and care, and award-winning InSite Events™ platform to successfully transfer their annual national meeting online....
Fear or encouragement, which is best to drive behaviour change?
The communications industry depends on fear of the perceived loss of something, in order to create the hope found in a product benefit. But, if if left too long unchecked,...
The unheard, unseen, and uncorrected effects of COVID-19
The disproportionate effects of the pandemic have been highlighted amongst ethnic minorities, so is it likely that ethnic minorities will be more worried about participating? And could this exacerbate inequalities...

Infographics